In a two-hour hearing on May 17 looking at the U.S. Food and Drug Administration’s decades-old approval of an abortion pill, federal judges seemed to have a harsher line of questioning for attorneys for the federal government and the drug maker, indicating they might be sympathetic to those challenging the drug’s availability.
5th U.S. Circuit Court of Appeals
Appeals Court Hears Abortion Pill Case, Next Stop Supreme Court
A federal appeals court in Louisiana is hearing arguments May 17 about the accessibility of the abortion drug mifepristone.